Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 20 of 20 entries
View as:

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02965495 Org: User:
Start: 11/30/16 End: 09/30/17 Due: 09/30/18

Prospective Observational Study of Pravafenix Cap

Phase: N/A Priority: Normal
NCT ID: NCT03214211 Org: User:
Start: 08/30/17 End: 06/30/22 Due: 06/30/23

Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02166593 Org: User:
Start: 05/31/14 End: 01/31/18 Due: 01/31/19

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT03170050 Org: User:
Start: 03/01/17 End: 11/21/17 Due: 11/21/18

Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT05362851 Org: User:
Start: 11/11/21 End: 03/31/23 Due: 03/31/24

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Phase: N/A Priority: Normal
NCT ID: NCT04874142 Org: User:
Start: 11/20/19 End: 03/23/20 Due: 03/23/21

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02554552 Org: User:
Start: 09/30/15 End: 10/31/16 Due: 10/31/17

A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT02382159 Org: User:
Start: 10/31/10 End: 06/30/15 Due: 06/30/16

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT05226897 Org: User:
Start: 07/12/21 End: 06/26/23 Due: 06/26/24

PK/PD Clinical Trial of YYD601 in Healthy Adult Male

Phase: N/A Priority: Normal
NCT ID: NCT03558477 Org: User:
Start: 09/19/17 End: 02/07/18 Due: 02/07/19

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Phase: N/A Priority: Normal
NCT ID: NCT04874129 Org: User:
Start: 01/07/21 End: 07/31/21 Due: 07/31/22

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS

Phase: N/A Priority: Normal
NCT ID: NCT05348525 Org: User:
Start: 07/31/22 End: 03/31/23 Due: 03/31/24

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03561779 Org: User:
Start: 02/21/18 End: 10/04/19 Due: 10/04/20

Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

Phase: N/A Priority: Normal
NCT ID: NCT03985319 Org: User:
Start: 07/08/19 End: 03/20/20 Due: 03/20/21

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO

Phase: N/A Priority: Normal
NCT ID: NCT05229458 Org: User:
Start: 05/31/22 End: 12/31/22 Due: 12/31/23

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03967886 Org: User:
Start: 04/10/19 End: 05/27/20 Due: 05/27/21

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03850587 Org: User:
Start: 08/30/18 End: 09/07/20 Due: 09/07/21

Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX

Phase: N/A Priority: Normal
NCT ID: NCT03555123 Org: User:
Start: 01/11/19 End: 07/30/22 Due: 07/30/23

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.

Phase: N/A Priority: Normal
NCT ID: NCT04858308 Org: User:
Start: 01/29/21 End: 01/31/22 Due: 01/31/23

Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)

Phase: N/A Priority: Normal
NCT ID: NCT03943992 Org: User:
Start: 01/29/19 End: 07/01/20 Due: 07/01/21